# Biomarker Rule in/Out in Patients With Acute Diseases for Validation of AKI (BRAVA) Acute Kidney Injury

> **NCT03754023** · — · COMPLETED · sponsor: **GREAT Network Italy** · enrollment: 818 (actual)

## Conditions studied

- Acute Kidney Injury

## Interventions

- **DIAGNOSTIC_TEST:** Urine-TIMP-IGFBP7 biomarker for AKI

## Key facts

- **NCT ID:** NCT03754023
- **Lead sponsor:** GREAT Network Italy
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-01
- **Primary completion:** 2019-06-30
- **Final completion:** 2019-11-30
- **Target enrollment:** 818 (ACTUAL)
- **Last updated:** 2021-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03754023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03754023, "Biomarker Rule in/Out in Patients With Acute Diseases for Validation of AKI (BRAVA) Acute Kidney Injury". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03754023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*